Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma
Clinical trial NCT01139359 · WITHDRAWN
Trial details
- NCT number
- NCT01139359
- Sponsor
- Alaunos Therapeutics
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.